Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jana Keslová-Veselíková
Replacement of Α-Galactosidase a in Fabry Disease: Effect on Fibroblast Cultures Compared With Biopsied Tissues of Treated Patients
Virchows Archiv
Medicine
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Related publications
Fabry Disease: Effective Tissue Substrate Depletion Following Enzyme Replacement in Α-Galactosidase a Deficient Mice. • 607
Pediatric Research
Child Health
Pediatrics
Perinatology
Adipocytes Participate in Storage in Α-Galactosidase Deficiency (Fabry Disease)
Journal of Inherited Metabolic Disease
Genetics
Receptor-Mediated Endocytosis of Α-Galactosidase a in Human Podocytes in Fabry Disease
PLoS ONE
Multidisciplinary
Modeling the Effect of Enzyme Replacement Therapy on Life-Threatening Complications in Patients With Fabry Disease
PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology
Fabry Disease: Twenty Novel Α-Galactosidase a Mutations Causing the Classical Phenotype
Journal of Human Genetics
Genetics
Novel Α-Galactosidase a Mutation (K391E) in a Young Woman With Severe Cardiac and Renal Manifestations of Fabry Disease
International Heart Journal
Medicine
Cardiovascular Medicine
Cardiology
Screening for Fabry Disease in Patients With Chronic Kidney Disease: Limitations of Plasma -Galactosidase Assay as a Screening Test
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients With Fabry Disease
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients With Fabry Disease
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology